0.503
Finanzdaten der Jaguar Health Inc-Aktie (JAGX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.49%
3.083
|
2.979 | 2.214 | 3.509 | 3.108 |
| Cost Of Revenue |
0.95%
0.532
|
0.527 | 0.515 | 0.557 | 0.541 |
| Gross Profit |
4.04%
2.551
|
2.452 | 1.699 | 2.952 | 2.567 |
|
|
6.41%
9.789
|
10.46 | 11.12 | 11.11 | 9.829 |
| Interest Income/Expense |
140.00%
0.006
|
-0.015 | -0.056 | -0.11 | -0.162 |
| Benefits Costs and Expenses |
5.97%
12.73
|
13.54 | 12.81 | 13.74 | 13.13 |
| Costs And Expenses |
6.05%
10.32
|
10.99 | 11.63 | 11.67 | 10.37 |
| Operating Income/Loss |
9.60%
-7.238
|
-8.007 | -9.421 | -8.157 | -7.262 |
| Income/Loss Before Equity Method Investments |
8.70%
-9.603
|
-10.52 | -10.56 | -10.17 | -9.989 |
| Income/Loss From Equity Method Investments |
7.14%
-0.045
|
-0.042 | -0.033 | -0.06 | -0.032 |
| Income/Loss From Continuing Operations Before Tax |
8.64%
-9.648
|
-10.56 | -10.60 | -10.23 | -10.02 |
| Income/Loss From Continuing Operations After Tax |
8.64%
-9.648
|
-10.56 | -10.60 | -10.23 | -10.02 |
|
|
8.64%
-9.648
|
-10.56 | -10.60 | -10.23 | -10.02 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
4.58%
-0.146
|
-0.153 | -0.132 | -0.314 | -0.167 |
| Basic Average Shares |
49.11%
1.5132
|
1.0148 | 0.6266 | -5.5544 | 9.3701 |
| Diluted Average Shares |
49.11%
1.5132
|
1.0148 | 0.6266 | -5.5544 | 9.3701 |
| Basic Earnings Per Share |
38.79%
-6.28
|
-10.26 | -16.70 | -125.80 | -1.05 |
| Diluted Earnings Per Share |
38.79%
-6.28
|
-10.26 | -16.70 | -125.80 | -1.05 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):